Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient’s unmet clinical needs. It’s our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring journey

**How you’ll make an impact:**

+ Provide recommendations and insights on the development and implementation of core lab screening/FU strategy and provide guidance from functional standpoint on strategy execution.
+ Develop methodologies based on core lab infrastructures and trial needs. Create tools and materials needed for success of echo quality from screening through follow up for sites from core lab.
+ Drives process' for trial needs overall (i.e. CRF redlining, data snap, sci comm reviews, data collection and monitoring). Develop and implement clinical a...